Skip to main content
Japanese Journal of Cancer Research : Gann logoLink to Japanese Journal of Cancer Research : Gann
. 2000 Jan;91(1):68–74. doi: 10.1111/j.1349-7006.2000.tb00861.x

Vitamin K Contents in Liver Tissue of Hepatocellular Carcinoma Patients

Takayuki Miyakawa 1,, Yasuhiro Kajiwara 1, Akira Shirahata 1, Kohji Okamoto 2, Hideaki Itoh 2, Keiichi Ohsato 2
PMCID: PMC5926228  PMID: 10744046

Abstract

Serum protein induced in vitamin K absence‐II (PIVKA‐II) is used as a tumor marker because it increases at a notably higher rate in patients with hepatocellular carcinoma. To clarify the mechanism causing the elevation of serum PIVKA‐II, we measured the contents of vitamins K1 (phylloquinone, PK) and K2 (menaquinone, MK) (MK‐4, MK‐5, MK‐6, MK‐7, MK‐8, MK‐9, MK‐10) in liver tissue resected from 21 hepatic cancer patients (12 patients with hepatocellular carcinoma and 9 patients with metastatic hepatic cancer), using HPLC combined with coulometric reduction and fluorometric detection. In the cancerous tissue of hepatocellular carcinoma patients, PK, MK‐7, MK‐8, and MK‐10 in the cancerous tissue of hepatocellular carcinoma patients were significantly lower than that in the cancerous tissue of metastatic hepatic cancer patients. These data suggested that one of the mechanisms of the elevation of serum PIVKA‐II levels in hepatocellular carcinoma patients is a vitamin K deficiency in the local cancerous tissue.

Keywords: Phylloquinone, Menaquinone, Protein induced in vitamin K absence‐II, Hepatocellular carcinoma, Metastatic hepatic cancer

Full Text

The Full Text of this article is available as a PDF (78.2 KB).

REFERENCES

  • 1. ) Suttie , J. W.The importance of menaquinones in human nutrition . Annu. Rev. Nutr. , 15 , 399 – 417 ( 1995. ). [DOI] [PubMed] [Google Scholar]
  • 2. ) Shearer , M. J.Vitamin K.Lancet , 345 , 229 – 234 ( 1995. ). [DOI] [PubMed] [Google Scholar]
  • 3. ) Hemker , H. C. and Muller , A. D.Kinetic aspects of the interaction of blood‐clotting enzyme.VI. Localization of the site of blood‐coagulation inhibition by the protein induced by vitamin K absence (PIVKA) . Thromb. Diath. Haemorrh. , 20 , 78 – 87 ( 1968. ). [PubMed] [Google Scholar]
  • 4. ) Ganrot , P. O. and Nilehn , J. E.Plasma prothrombin during treatment with dicumarol. II. Demonstration of an abnormal prothrombin fraction . Scand. J. Clin. Lab. Invest. , 22 , 23 – 28 ( 1968. ). [PubMed] [Google Scholar]
  • 5. ) Stenflo , J. , Fernlund , P. , Egan , W. and Roepstoref , P.Vitamin K dependent modifications of glutamic acid residue in prothrombin . Proc. Natl. Acad. Sci. USA , 71 , 2730 – 2733 ( 1974. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6. ) Nelsestuen , G. L. and Suttie , J. W.The purification and properties of an abnormal prothrombin protein produced by dicumarol‐treated cows . J. Biol. Chem. , 247 , 8176 – 8182 ( 1972. ). [PubMed] [Google Scholar]
  • 7. ) Liebman , H. A. , Furie , B. C. , Tong , M. J. , Blanchard , R. A. , Lo , K.‐J. , Lee , S.‐D. , Coleman , M. S. and Furie , B.Des‐γ‐carboxy (abnormal) prothrombin as a serum marker of primary hepatocellular carcinoma . N. Engl. J. Med. , 310 , 1427 – 1431 ( 1984. ). [DOI] [PubMed] [Google Scholar]
  • 8. ) Motohara , K. , Kuroki , Y. , Kan , H. , Endo , F. and Matsuda , I.Detection of vitamin K deficiency by use of an enzymelinked immunosorbent assay for circulating abnormal prothrombin . Pediatr. Res. , 19 , 354 – 357 ( 1985. ). [DOI] [PubMed] [Google Scholar]
  • 9. ) Fujiyama , S. , Morishita , T. , Sagara , K. , Sato , T. , Motohara , K. and Matsuda , I.Clinical evaluation of plasma abnormal prothrombin (PIVKA‐II) in patients with hepatocellular carcinoma . Hepatogastroenterology , 33 , 201 – 205 ( 1986. ). [PubMed] [Google Scholar]
  • 10. ) Fujiyama , S. , Morishita , T. , Hashiguchi , O. and Sato , T.Plasma abnormal prothrombin (des‐γ‐carboxy prothrombin) as a marker of hepatocellular carcinoma . Cancer , 61 , 1621 – 1628 ( 1988. ). [DOI] [PubMed] [Google Scholar]
  • 11. ) Fujiyama , S. , Izuno , K. , Gohshi , K. , Shibata , J. and Sato , T.Clinical usefulness of evaluation of des‐γ‐carboxy prothrombin assay in early diagnosis of hepatocellular carcinoma . Dig. Dis. Sci. , 36 , 1787 – 1792 ( 1991. ). [DOI] [PubMed] [Google Scholar]
  • 12. ) Soulier , J.‐P. , Gozin , D. and Lefrere , J.‐J.A new method to assay des‐γ‐carboxyprothrombin . Gastroenterology , 91 , 1258 – 1262 ( 1986. ). [DOI] [PubMed] [Google Scholar]
  • 13. ) Tsai , S. L. , Huang , G. T. , Yang , P. M. , Sheu , J. C. and Chen , D. S.Plasma des‐γ‐carboxyprothrombin in the early stage of hepatocellular carcinoma . Hepatology , 11 , 481 – 488 ( 1990. ). [DOI] [PubMed] [Google Scholar]
  • 14. ) Hirauchi , K. , Sakano , T. , Notsumoto , S. , Nagaoka , T. , Morimoto , A. , Fujimoto , K. , Matsuda , S. and Suzuki , Y.Measurement of K vitamins in animal tissues by high‐performance liquid chromatography with fluorimetric detection . J. Chromatogr. , 497 , 131 – 137 ( 1989. ). [DOI] [PubMed] [Google Scholar]
  • 15. ) Hirauchi , K. , Sakano , T. and Morimoto , A.Measurement of K vitamins in human and animal plasma by high‐performance liquid chromatography with fluorometric detection . Chem. Pharm. Bull. , 34 , 845 – 849 ( 1986. ). [DOI] [PubMed] [Google Scholar]
  • 16. ) Hirauchi , K. , Sakano , T. , Nagaoka , T. and Morimoto , A.Simultaneous determination of vitamin K1, vitamin K1 2,3‐epoxide and menaquinone‐4 in human plasma by high‐performance liquid chromatography with fluorimetric detection . J. Chromatogr. , 430 , 21 – 29 ( 1988. ). [DOI] [PubMed] [Google Scholar]
  • 17. ) Huisse , M.‐G. , Leclercq , M. , Belghiti , J. , Flejou , J.‐F. , Suttie , J. W. , Bezeaud , A. , Stafford , D. W. and Guillin , M.‐C.Mechanism of the abnormal vitamin K‐dependent γ‐carboxylation process in human hepatocellular carcinomas . Cancer , 74 , 1533 – 1541 ( 1994. ). [DOI] [PubMed] [Google Scholar]
  • 18. ) Ono , M. , Ohta , H. , Ohhira , M. , Sekiya , C. and Namiki , M.Measurement of immunoreactive prothrombin, des‐γ‐carboxy prothrombin, and vitamin K in human liver tissue: overproduction of immunoreactive prothrombin in hepatocellular carcinoma . Am. J. Gastroenterol. , 85 , 1149 – 1154 ( 1990. ). [PubMed] [Google Scholar]
  • 19. ) Yamagata , H. , Nakanishi , T. , Furukawa , M. , Okuda , H. and Obata , H.Levels of vitamin K, immunoreactive prothrombin, des‐γ‐carboxy prothrombin and γ‐glutamyl carboxylase activity in hepatocellular carcinoma tissue . J. Gastroenterol. Hepatol. , 10 , 8 – 13 ( 1995. ). [DOI] [PubMed] [Google Scholar]
  • 20. ) Shah , D. V. , Zhang , P. , Engelke , J. A. , Bach , A. U. and Suttie , J. W.Vitamin K‐dependent carboxylase activity, prothrombin mRNA, and prothrombin production in two cultured rat hepatoma cell lines . Thromb. Res. , 70 , 365 – 373 ( 1993. ). [DOI] [PubMed] [Google Scholar]
  • 21. ) Tagawa , M. , Omata , M. and Ohta , M.Nucleotide sequence of prothrombin gene in abnormal prothrombin‐producing hepatocellular carcinoma cell lines . Cance , 69 , 643 – 647 ( 1992. ). [DOI] [PubMed] [Google Scholar]
  • 22. ) Buitenhuis , H. C. , Soute , B. A. M. and Vermeer , C.Comparison of the vitamins K1, K2, and K3 as cofactors for the hepatic vitamin K‐dependent carboxylase . Biochim. Biophys. Acta , 1034 , 170 – 175 ( 1990. ). [DOI] [PubMed] [Google Scholar]
  • 23. ) Reedstrom , C. T. and Suttie , J. W.Comparative distribution, metabolism, and utilization of phylloquinone and menaquinone‐9 in rat liver . Exp. Biol. Med. , 209 , 403 – 409 ( 1994. ). [DOI] [PubMed] [Google Scholar]
  • 24. ) Friedman , P. A. and Shia , M.Some characteristics of a vitamin K‐dependent carboxylating system from rat liver microsomes . Biochem. Biophys. Res. Commun. , 70 , 647 – 654 ( 1976. ). [DOI] [PubMed] [Google Scholar]
  • 25. ) Jones , J. P. , Fausto , A. , Houser , R. M. , Gardner , E. J. and Olson , R. E.Effect of vitamin K homologues on the conversion of preprothrombin to prothrombin in rat liver microsomes . Biochem. Biophys. Res. Commun. , 72 , 589 – 597 ( 1976. ). [DOI] [PubMed] [Google Scholar]
  • 26. ) Yen , C. S. and Mac , D. O.Solubilized rat liver vitamin K carboxylase demonstrates little selectivity between vitamin K1 and the menaquinones . Proc. Soc. Exp. Biol. Med. , 165 , 306 – 308 ( 1980. ). [DOI] [PubMed] [Google Scholar]
  • 27. ) Cheung , A. Y. , Wood , G. M. , Funakawa , S. , Grossman , C. P. and Suttie , J. W.Vitamin K‐dependent carboxylase: substrates, products, and inhibitors . In “ Current Advances in Vitamin K Research ,” ed. Suttie J. W. , pp. 3 – 16 ( 1987. ). Elsevier; , New York . [Google Scholar]
  • 28. ) Usui , Y. , Nishimura , N. , Kobayashi , N. , Okanoue , T. , Kimoto , M. and Ozawa , K.Measurement of K vitamins in human liver by gradient elution high‐performance liquid chromatography using platinum‐black catalyst reduction and fluorometric detection . J. Chromatogr. , 489 , 291 – 301 ( 1989. ). [DOI] [PubMed] [Google Scholar]

Articles from Japanese Journal of Cancer Research : Gann are provided here courtesy of Wiley

RESOURCES